3MO Efficacy of neoadjuvant pembrolizuamb in early triple-negative breast cancer according to germline BRCA-1/2 mutation.

Autor:	Bae, S.J.1 (AUTHOR), Ho, B. Seung2 (AUTHOR), Kook, Y.3 (AUTHOR), Kim, J.H.4 (AUTHOR), Minji, L.5 (AUTHOR), Ahn, S.G.1 (AUTHOR), Jeong, J.1 (AUTHOR)
Zdroj:	Annals of Oncology. 2024 Supplement 4, Vol. 35, pS1406-S1406. 1p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu